Mulpleta (lusutrombopag) is used to raise the platelet count in adults with long-term liver problems scheduled to undergo a procedure. Although it's convenient because it's taken by mouth once per day for a total of 7 days, it's expensive since it's a brand medication only.
Mulpleta (lusutrombopag) is a thrombopoietin receptor agonist, meaning it acts like TPO. TPO is a natural hormone that tells your bone marrow to make more platelets. So Mulpleta (lusutrombopag) works by raising your platelets and helps to lower your risk for bleeding in preparation for a procedure.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Reported from clinical trials
Contact your healthcare provider immediately if you experience any of the following.
A common problem in people with long-term liver problems is a low platelet count, also known as thrombocytopenia. Platelets are small cells in your blood that clump together and form plugs to stop or prevent bleeding. Mulpleta (lusutrombopag) is used to raise the number of platelets in your blood so you don't bleed too much by the time you undergo a procedure.
No. At this time, Mulpleta (lusutrombopag) is only FDA approved for short-term use in people with long-term liver problems in preparation for a procedure. If you have long-term liver problems and are looking for long-term treatment to raise your platelets, discuss with your provider about other medication options.
Your provider will have you start taking Mulpleta (lusutrombopag) about 8 to 14 days before your scheduled procedure. Mulpleta (lusutrombopag) is taken for 7 days and then you'll undergo your procedure 2 to 8 days after your last dose.
It's not known if Mulpleta (lusutrombopag) is safe or works well in children younger than 18 years old. Talk to your child's provider about other options if your child has liver problems and needs to undergo a procedure.
There haven't been studies done on how Mulpleta (lusutrombopag) affects pregnant women. Based on animal studies, Mulpleta (lusutrombopag) might cause harm to unborn babies. Mulpleta (lusutrombopag) should only be given in pregnancy if it's absolutely needed. If you're pregnant or thinking of becoming pregnant, talk to your provider to make sure Mulpleta (lusutrombopag) is right for you.
Mulpleta (lusutrombopag) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Since Mulpleta (lusutrombopag) raises the number of platelets in your blood, there is a risk of clotting, including a condition called portal vein thrombosis. Portal vein thrombosis is a clot in the major vein of your liver. This is rare though, as it happened in about 1% of people taking Mulpleta (lusutrombopag) during clinical studies. Still, contact your provider as soon as possible if you experience stomach pain, nausea, or fever because these might be signs of portal vein thrombosis.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 7 tablets of 3mg | 1 dose pack | $8,166.23 | $8,166.23 |
The typical dose is 3 mg by mouth once a day for 7 days.